Human Ubiquitin-Specific Peptidase 18 Is Regulated by microRNAs

22q11.2 3'untranslated region, microRNAs Testis long intergenic non-coding RNA type I interferon ubiquitin-specific peptidase

Journal

Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621

Informations de publication

Date de publication:
2020
Historique:
received: 07 11 2020
accepted: 30 12 2020
entrez: 26 2 2021
pubmed: 27 2 2021
medline: 27 2 2021
Statut: epublish

Résumé

Ubiquitin-specific peptidase 18 (USP18) acts as gatekeeper of type I interferon (IFN) responses by binding to the IFN receptor subunit IFNAR2 and preventing activation of the downstream JAK/STAT pathway. In any given cell type, the level of USP18 is a key determinant of the output of IFN-stimulated transcripts. How the baseline level of USP18 is finely tuned in different cell types remains ill defined. Here, we identified microRNAs (miRNAs) that efficiently target

Identifiants

pubmed: 33633774
doi: 10.3389/fgene.2020.627007
pmc: PMC7901961
doi:

Types de publication

Journal Article

Langues

eng

Pagination

627007

Informations de copyright

Copyright © 2021 Rubino, Cruciani, Tchitchek, Le Tortorec, Rolland, Veli, Vallet, Gaggi, Michel, Dejucq-Rainsford and Pellegrini.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Nat Immunol. 2011 Nov 20;13(1):51-7
pubmed: 22101728
PLoS Pathog. 2013 Oct;9(10):e1003650
pubmed: 24204252
Lancet Infect Dis. 2020 Dec;20(12):1371
pubmed: 33248032
Hum Reprod. 2019 Jul 8;34(7):1278-1290
pubmed: 31247106
Cell Rep. 2020 May 12;31(6):107633
pubmed: 32402279
J Biol Chem. 1988 Aug 25;263(24):12151-5
pubmed: 3403564
Am J Med Genet A. 2018 Oct;176(10):2070-2081
pubmed: 30380194
Cell Rep. 2018 Dec 4;25(10):2784-2796.e3
pubmed: 30517866
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
J Immunol. 2008 Sep 1;181(5):2999-3008
pubmed: 18713970
PLoS One. 2020 Mar 26;15(3):e0230236
pubmed: 32214344
Genes Dev. 2011 Sep 15;25(18):1915-27
pubmed: 21890647
Nat Rev Dis Primers. 2015 Nov 19;1:15071
pubmed: 27189754
Nat Rev Immunol. 2011 Oct 10;11(11):762-74
pubmed: 21984070
EMBO J. 1988 Dec 1;7(12):3757-62
pubmed: 3208748
PLoS One. 2012;7(1):e29979
pubmed: 22276136
Sci Rep. 2019 Mar 11;9(1):4066
pubmed: 30858391
J Neuroinflammation. 2016 Oct 24;13(1):277
pubmed: 27776548
Nat Biotechnol. 2017 Sep;35(9):872-878
pubmed: 28829439
Nature. 2010 Jun 24;465(7301):1033-8
pubmed: 20577206
Curr Biol. 2012 Nov 6;22(21):R898-9
pubmed: 23137679
Genome Res. 2019 Sep;29(9):1389-1401
pubmed: 31481461
Nat Commun. 2016 Aug 17;7:12339
pubmed: 27531712
Cell. 2015 Apr 9;161(2):319-32
pubmed: 25843629
Nature. 2015 Jan 1;517(7532):89-93
pubmed: 25307056
Hum Mol Genet. 2007 Nov 1;16(21):2560-71
pubmed: 17675367
J Clin Invest. 2018 Oct 1;128(10):4697-4710
pubmed: 30063220
Nat Struct Mol Biol. 2017 Mar;24(3):279-289
pubmed: 28165510
Physiol Rev. 2020 Jul 1;100(3):1349-1414
pubmed: 32031468
Noncoding RNA. 2020 Sep 03;6(3):
pubmed: 32899105
Cell Rep. 2013 Jun 27;3(6):2179-90
pubmed: 23791531
Cell. 2012 Apr 27;149(3):515-24
pubmed: 22541426
Biosci Rep. 2018 Nov 15;38(6):
pubmed: 30126853
J Cell Biol. 2015 May 25;209(4):579-93
pubmed: 26008745
Genes Immun. 2014 Jul-Aug;15(5):282-92
pubmed: 24807690
Mol Syst Biol. 2020 Jul;16(7):e8955
pubmed: 32696599
Front Immunol. 2015 Jul 08;6:334
pubmed: 26217335
Cell Death Dis. 2016 Nov 3;7(11):e2444
pubmed: 27809302
Nat Commun. 2016 May 19;7:11496
pubmed: 27193971
EMBO J. 2015 Jun 12;34(12):1612-29
pubmed: 25896511
Cell Res. 2018 Dec;28(12):1141-1157
pubmed: 30315278
Acta Neuropathol Commun. 2019 Jul 4;7(1):106
pubmed: 31272490
J Exp Med. 2016 Jun 27;213(7):1163-74
pubmed: 27325888
PLoS One. 2018 Apr 18;13(4):e0195702
pubmed: 29668722
J Biol Chem. 2011 Jul 1;286(26):23280-95
pubmed: 21515676
PLoS Biol. 2010 Apr 27;8(4):e1000361
pubmed: 20436908
PLoS One. 2011;6(7):e22200
pubmed: 21779393
Genome Res. 2003 Dec;13(12):2519-32
pubmed: 14656960
Trends Immunol. 2008 Jul;29(7):343-51
pubmed: 18515182
EMBO J. 2006 Jun 7;25(11):2358-67
pubmed: 16710296
Nat Cell Biol. 2019 May;21(5):542-551
pubmed: 31048766

Auteurs

Erminia Rubino (E)

Unit of Cytokine Signaling, Institut Pasteur, INSERM U1221, Paris, France.
École Doctorale Physiologie, Physiopathologie et Thérapeutique, ED394, Sorbonne Université, Paris, France.

Melania Cruciani (M)

Unit of Cytokine Signaling, Institut Pasteur, INSERM U1221, Paris, France.

Nicolas Tchitchek (N)

École Doctorale Physiologie, Physiopathologie et Thérapeutique, ED394, Sorbonne Université, Paris, France.
i3 research unit, Hôpital Pitié-Salpêtrière-Sorbonne Université, Paris, France.

Anna Le Tortorec (A)

UMR_S1085, Institut de recherche en santé, environnement et travail (Irset), EHESP, Inserm, Univ Rennes, Rennes, France.

Antoine D Rolland (AD)

UMR_S1085, Institut de recherche en santé, environnement et travail (Irset), EHESP, Inserm, Univ Rennes, Rennes, France.

Önay Veli (Ö)

Unit of Cytokine Signaling, Institut Pasteur, INSERM U1221, Paris, France.

Leslie Vallet (L)

Unit of Cytokine Signaling, Institut Pasteur, INSERM U1221, Paris, France.

Giulia Gaggi (G)

Unit of Cytokine Signaling, Institut Pasteur, INSERM U1221, Paris, France.

Frédérique Michel (F)

Unit of Cytokine Signaling, Institut Pasteur, INSERM U1221, Paris, France.

Nathalie Dejucq-Rainsford (N)

UMR_S1085, Institut de recherche en santé, environnement et travail (Irset), EHESP, Inserm, Univ Rennes, Rennes, France.

Sandra Pellegrini (S)

Unit of Cytokine Signaling, Institut Pasteur, INSERM U1221, Paris, France.

Classifications MeSH